Peter P. Pfreundschuh
2014 - Immunomedics
In 2014, Peter P. Pfreundschuh earned a total compensation of $566.1K as Former VP Finance and Chief Financial Officer at Immunomedics.
Compensation breakdown
Non-Equity Incentive Plan | $75,000 |
---|---|
Option Awards | $253,860 |
Salary | $235,490 |
Other | $1,781 |
Total | $566,131 |
Pfreundschuh received $253.9K in option awards, accounting for 45% of the total pay in 2014.
Pfreundschuh also received $75K in non-equity incentive plan, $235.5K in salary and $1.8K in other compensation.
Rankings
In 2014, Peter P. Pfreundschuh's compensation ranked 9,873rd out of 13,032 executives tracked by ExecPay. In other words, Pfreundschuh earned more than 24.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,873 | 24th |
Manufacturing | 3,743 | 25th |
Chemicals And Allied Products | 1,284 | 24th |
Drugs | 1,024 | 25th |
In Vitro and In Vivo Diagnostic Substances | 45 | 38th |
Pfreundschuh's colleagues
We found two more compensation records of executives who worked with Peter P. Pfreundschuh at Immunomedics in 2014.
News
Korro Bio CEO David Lucchino's 2020 pay falls 29% to $5.2M
April 29, 2021
UroGen Pharma Ltd. CEO Elizabeth Barrett's 2020 pay falls 90% to $2.5M
April 28, 2021
UroGen Pharma Ltd. CEO Elizabeth Barrett receives $26M in 2019
April 29, 2020
UroGen Pharma Ltd. CEO Ron Bentsur's 2018 pay jumps 202% to $6M
April 26, 2019